News
The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.
CVS Health Corp CVS reported first-quarter sales ... Advantage star ratings for the 2025 payment year. Also Read: FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth's PBMs Amid Commissioner ...
14d
Zacks Investment Research on MSNCVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter ...
But, less than two months later, the company is in a state of free fall. Its collapse reflects not simply the troubles of the ...
President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his executive order on drug pricing, saying he would cut them out as part of a goal ...
An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly excessive fees paid by ERISA health plan sponsors (in their fiduciary ...
Regeneron Trial Team Talks $406.8M Win in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen
Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...
Amid abuses to consumers by big corporations, the Federal Trade Commission Act was passed in 1914. Antitrust enforcement by ...
While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...
It takes Kathy Younkins just a few minutes to walk to her neighborhood Rite Aid. The 67-year-old has picked up her ...
The inflated prices in the United States fuel global innovation while foreign health systems get a free ride.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results